Antiosteoporosis Medication Prescriptions After Fragility Fractures

This cohort study assesses prescribing rates for antiosteoporosis medication following a fragility fracture and factors associated with filling a prescription after a fracture among patients in Ontario, Canada.

Saved in:

Bibliographic Details
Published in:	JAMA network open Vol. 7; no. 10; p. e2438393
Main Authors:	Silverstein, William K, Wang, Sping, Alavinejad, Mahnaz, Sarnocinska, Ania, Stall, Nathan M, Malikov, Kamil, Hillmer, Michael P, Zipursky, Jonathan S
Format:	Journal Article
Language:	English
Published:	United States American Medical Association 01-10-2024
Subjects:	Aged Aged, 80 and over Bone Density Conservation Agents - therapeutic use Drug Prescriptions - statistics & numerical data Female Humans Male Middle Aged Online Only Orthopedics Osteoporosis - drug therapy Osteoporotic Fractures - drug therapy Osteoporotic Fractures - prevention & control Research Letter
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	This cohort study assesses prescribing rates for antiosteoporosis medication following a fragility fracture and factors associated with filling a prescription after a fracture among patients in Ontario, Canada.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2574-3805 2574-3805
DOI:	10.1001/jamanetworkopen.2024.38393